Diabetes Mellitus, Hypertension, and PPAR- Gamma Agonist-Rosiglitazone Alter Calcium Handling and Enhance Arrhythmogenesis

Research output: Contribution to journalArticle

Abstract

Background: Diabetes and hypertension have significant effects on cardiac calcium(Ca2+) regulation which plays essential role in cardiac function. The effect of peroxisome proliferator-activated receptor (PPAR)-gamma agonists on Ca2+ regulation in cardiomyocytes is unclear. Objective The purpose is to investigate the effects of hypertension, diabetes, and PPAR- δ agonist-rosiglitazone on regulation of Ca2+ and electrophysiological characteristics of isolated ventricular myocytes. Methods: Indo-Recent studies showed that the genetic Variation of SCN5A is related with atrioventricular block. But there was no study included Korean patients. To determine the complete atrioventricular block (CAVB) associated genetic variation in Korean patients, we investigated the genetic variation of the SCN5A in Korean patients with CAVB. We enrolled 10 patients with CAVB and 30 normal control. DNA was isolated from the each peripheral blood, and all the exons except untranslated region and exon-intron boundaries of the SCN5A gene were amplified by PCR and directly sequenced using an ABI PRISM 3100 Genetic Analyzer. When a variation was discovered in genomic DNA from AVB patients, confirmed whether the same variation existed in the control genomic DNA. A total of 7 genetic variations (5 known and 2 novel) were detected in 10 AVB patients. Of the 7 variations, 5 (G87A-A29A, IVS9-3C>A, A1673G-H558R, G3578A-R1193Q, T5457C-D1819D) have been reported in previous studies and 2 (C48G-F16L, G3048A-T1016T) were novel variations which have not been reported. Newly discovered 2 variations, non-synonymous change (C48G-F16L) and synonymous (G3048A-T1016T) were not found in 30 normal control group. In conclusion, we found 2 novel genetic variations (C48G-F16L, G3048A-T1016T) in the SCN5A gene in Korean patients with CAVB.

Original languageEnglish
Pages (from-to)426
Number of pages1
JournalJournal of Arrhythmia
Volume27
Issue number4
DOIs
Publication statusPublished - 2011

Fingerprint

rosiglitazone
PPAR gamma
Diabetes Mellitus
Atrioventricular Block
Hypertension
Calcium
Exons
DNA
Untranslated Regions
Peroxisome Proliferator-Activated Receptors
Cardiac Myocytes
Introns
Muscle Cells
Genes

Keywords

  • Calcium Handling
  • diabetes melitus
  • hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{f6aafc4c32ea4e49975ae564f13a1ad1,
title = "Diabetes Mellitus, Hypertension, and PPAR- Gamma Agonist-Rosiglitazone Alter Calcium Handling and Enhance Arrhythmogenesis",
abstract = "Background: Diabetes and hypertension have significant effects on cardiac calcium(Ca2+) regulation which plays essential role in cardiac function. The effect of peroxisome proliferator-activated receptor (PPAR)-gamma agonists on Ca2+ regulation in cardiomyocytes is unclear. Objective The purpose is to investigate the effects of hypertension, diabetes, and PPAR- δ agonist-rosiglitazone on regulation of Ca2+ and electrophysiological characteristics of isolated ventricular myocytes. Methods: Indo-Recent studies showed that the genetic Variation of SCN5A is related with atrioventricular block. But there was no study included Korean patients. To determine the complete atrioventricular block (CAVB) associated genetic variation in Korean patients, we investigated the genetic variation of the SCN5A in Korean patients with CAVB. We enrolled 10 patients with CAVB and 30 normal control. DNA was isolated from the each peripheral blood, and all the exons except untranslated region and exon-intron boundaries of the SCN5A gene were amplified by PCR and directly sequenced using an ABI PRISM 3100 Genetic Analyzer. When a variation was discovered in genomic DNA from AVB patients, confirmed whether the same variation existed in the control genomic DNA. A total of 7 genetic variations (5 known and 2 novel) were detected in 10 AVB patients. Of the 7 variations, 5 (G87A-A29A, IVS9-3C>A, A1673G-H558R, G3578A-R1193Q, T5457C-D1819D) have been reported in previous studies and 2 (C48G-F16L, G3048A-T1016T) were novel variations which have not been reported. Newly discovered 2 variations, non-synonymous change (C48G-F16L) and synonymous (G3048A-T1016T) were not found in 30 normal control group. In conclusion, we found 2 novel genetic variations (C48G-F16L, G3048A-T1016T) in the SCN5A gene in Korean patients with CAVB.",
keywords = "Calcium Handling, diabetes melitus, hypertension",
author = "Lee, {Ting I.} and Chen, {Yao Chang} and Kao, {Yu Hsun} and Lin, {Yung Kuo} and Chen, {Yi Jen}",
year = "2011",
doi = "10.4020/jhrs.27.CP3_03",
language = "English",
volume = "27",
pages = "426",
journal = "Journal of Arrhythmia",
issn = "1880-4276",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Diabetes Mellitus, Hypertension, and PPAR- Gamma Agonist-Rosiglitazone Alter Calcium Handling and Enhance Arrhythmogenesis

AU - Lee, Ting I.

AU - Chen, Yao Chang

AU - Kao, Yu Hsun

AU - Lin, Yung Kuo

AU - Chen, Yi Jen

PY - 2011

Y1 - 2011

N2 - Background: Diabetes and hypertension have significant effects on cardiac calcium(Ca2+) regulation which plays essential role in cardiac function. The effect of peroxisome proliferator-activated receptor (PPAR)-gamma agonists on Ca2+ regulation in cardiomyocytes is unclear. Objective The purpose is to investigate the effects of hypertension, diabetes, and PPAR- δ agonist-rosiglitazone on regulation of Ca2+ and electrophysiological characteristics of isolated ventricular myocytes. Methods: Indo-Recent studies showed that the genetic Variation of SCN5A is related with atrioventricular block. But there was no study included Korean patients. To determine the complete atrioventricular block (CAVB) associated genetic variation in Korean patients, we investigated the genetic variation of the SCN5A in Korean patients with CAVB. We enrolled 10 patients with CAVB and 30 normal control. DNA was isolated from the each peripheral blood, and all the exons except untranslated region and exon-intron boundaries of the SCN5A gene were amplified by PCR and directly sequenced using an ABI PRISM 3100 Genetic Analyzer. When a variation was discovered in genomic DNA from AVB patients, confirmed whether the same variation existed in the control genomic DNA. A total of 7 genetic variations (5 known and 2 novel) were detected in 10 AVB patients. Of the 7 variations, 5 (G87A-A29A, IVS9-3C>A, A1673G-H558R, G3578A-R1193Q, T5457C-D1819D) have been reported in previous studies and 2 (C48G-F16L, G3048A-T1016T) were novel variations which have not been reported. Newly discovered 2 variations, non-synonymous change (C48G-F16L) and synonymous (G3048A-T1016T) were not found in 30 normal control group. In conclusion, we found 2 novel genetic variations (C48G-F16L, G3048A-T1016T) in the SCN5A gene in Korean patients with CAVB.

AB - Background: Diabetes and hypertension have significant effects on cardiac calcium(Ca2+) regulation which plays essential role in cardiac function. The effect of peroxisome proliferator-activated receptor (PPAR)-gamma agonists on Ca2+ regulation in cardiomyocytes is unclear. Objective The purpose is to investigate the effects of hypertension, diabetes, and PPAR- δ agonist-rosiglitazone on regulation of Ca2+ and electrophysiological characteristics of isolated ventricular myocytes. Methods: Indo-Recent studies showed that the genetic Variation of SCN5A is related with atrioventricular block. But there was no study included Korean patients. To determine the complete atrioventricular block (CAVB) associated genetic variation in Korean patients, we investigated the genetic variation of the SCN5A in Korean patients with CAVB. We enrolled 10 patients with CAVB and 30 normal control. DNA was isolated from the each peripheral blood, and all the exons except untranslated region and exon-intron boundaries of the SCN5A gene were amplified by PCR and directly sequenced using an ABI PRISM 3100 Genetic Analyzer. When a variation was discovered in genomic DNA from AVB patients, confirmed whether the same variation existed in the control genomic DNA. A total of 7 genetic variations (5 known and 2 novel) were detected in 10 AVB patients. Of the 7 variations, 5 (G87A-A29A, IVS9-3C>A, A1673G-H558R, G3578A-R1193Q, T5457C-D1819D) have been reported in previous studies and 2 (C48G-F16L, G3048A-T1016T) were novel variations which have not been reported. Newly discovered 2 variations, non-synonymous change (C48G-F16L) and synonymous (G3048A-T1016T) were not found in 30 normal control group. In conclusion, we found 2 novel genetic variations (C48G-F16L, G3048A-T1016T) in the SCN5A gene in Korean patients with CAVB.

KW - Calcium Handling

KW - diabetes melitus

KW - hypertension

UR - http://www.scopus.com/inward/record.url?scp=85009577502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009577502&partnerID=8YFLogxK

U2 - 10.4020/jhrs.27.CP3_03

DO - 10.4020/jhrs.27.CP3_03

M3 - Article

AN - SCOPUS:85009577502

VL - 27

SP - 426

JO - Journal of Arrhythmia

JF - Journal of Arrhythmia

SN - 1880-4276

IS - 4

ER -